These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Design, synthesis, and optimization of a series of 2-azaspiro[3.3]heptane derivatives as orally bioavailable fetal hemoglobin inducers. Katayama K; Tsunemi T; Miyazaki K; Uoto K; Yoshioka R; Terashima H; Terakawa M; Yamashiro K; Haruyama M; Maeda H; Makino T Bioorg Med Chem Lett; 2020 Oct; 30(19):127425. PubMed ID: 32717372 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia. Haghpanah S; Zarei T; Eshghi P; Zekavat O; Bordbar M; Hoormand M; Karimi M Ann Hematol; 2018 Oct; 97(10):1919-1924. PubMed ID: 29926158 [TBL] [Abstract][Full Text] [Related]
28. Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies. Testa U Ann Hematol; 2009 Jun; 88(6):505-28. PubMed ID: 19011856 [TBL] [Abstract][Full Text] [Related]
29. Vanadate elevates fetal hemoglobin in human erythroid precursors by inhibiting cell maturation. Amoyal I; Prus E; Fibach E Exp Biol Med (Maywood); 2007 May; 232(5):654-61. PubMed ID: 17463162 [TBL] [Abstract][Full Text] [Related]
30. MS-275 Chemical Analogues Promote Hemoglobin Production and Erythroid Differentiation of K562 Cells. Voskou S; Phylactides M; Afantitis A; Melagraki G; Tsoumanis A; Koutentis PA; Mitsidi T; Mirallai SI; Kleanthous M Hemoglobin; 2019 Mar; 43(2):116-121. PubMed ID: 31280628 [TBL] [Abstract][Full Text] [Related]
31. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937 [TBL] [Abstract][Full Text] [Related]
32. Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients. Fibach E; Bianchi N; Borgatti M; Zuccato C; Finotti A; Lampronti I; Prus E; Mischiati C; Gambari R Eur J Haematol; 2006 Nov; 77(5):437-41. PubMed ID: 16939628 [TBL] [Abstract][Full Text] [Related]
33. Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210. Sarakul O; Vattanaviboon P; Tanaka Y; Fucharoen S; Abe Y; Svasti S; Umemura T Blood Cells Mol Dis; 2013 Aug; 51(2):98-103. PubMed ID: 23623309 [TBL] [Abstract][Full Text] [Related]
34. HbF in HbE/β-thalassemia: A clinical and laboratory correlation. Lim WF; Muniandi L; George E; Sathar J; Teh LK; Lai MI Hematology; 2015 Jul; 20(6):349-53. PubMed ID: 25243862 [TBL] [Abstract][Full Text] [Related]
35. Disorders of the synthesis of human fetal hemoglobin. Manca L; Masala B IUBMB Life; 2008 Feb; 60(2):94-111. PubMed ID: 18379999 [TBL] [Abstract][Full Text] [Related]
36. Novel valproic acid derivatives with hemoglobin F inducing activity. Rönndahl G; Mönkemeyer S; Schulze S; Pekrun A; Eikel D; Nau H; Witt O Am J Hematol; 2006 May; 81(5):374-6. PubMed ID: 16628726 [TBL] [Abstract][Full Text] [Related]
37. Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: induction of production of fetal hemoglobin in human erythroid precursor cells. Bianchi N; Borgatti M; Fibach E; Prus E; Zuccato C; Breveglieri G; Baraldi PG; Romagnoli R; Gambari R Int J Mol Med; 2009 Jan; 23(1):105-11. PubMed ID: 19082513 [TBL] [Abstract][Full Text] [Related]